CMIS China Pharmaceutical Digital & Intelligent Summit
The digital transformation of China's pharmaceutical industry has become an inevitable choice for pharmaceutical enterprises to grasp trends and pursue high-quality development. On October 27-28, the "CMIS China Pharmaceutical Digital & Intelligent Summit" was successfully held in Shanghai. With the theme of "Laying a Foundation with IT Application Innovation and Empowering Development with Digital Intelligence", the conference focused on exchanges regarding strategic layout, industry pain points, and innovative solutions. The summit was guided by the Shanghai Pharmaceutical Industry Association and supported by the Zhejiang Digital Economy Federation. Hippocrates Health Technology Co., Ltd. was invited to participate in this event.
The CMIS Awards Ceremony, an important part of this Pharmaceutical Digital & Intelligent Summit, aims to recognize enterprises and individuals that have made outstanding achievements in the digital and intelligent transformation of the pharmaceutical industry and demonstrated excellent performance in corresponding fields. It emphasizes the importance of digital transformation, shares the achievements of industry innovation, and promotes the faster, better, and stronger development of the industry. Relying on its strong technical strength and rich practical experience, Hippocrates has won wide recognition and affirmation in the industry and was awarded the "Annual Innovation Award for Pharmaceutical Digital Solutions".
Mr. Tan Jie, Vice President of Hippocrates (second from the right), attended the award ceremony and accepted the award on behalf of the company.
About OwITrust® Digital Platform
OwITrust® is a quality and compliance integrated digital platform developed by Hippocrates with the joint efforts of experts in the GMP industry and digital field. It is strictly built in accordance with standards and regulations such as GMP, CGMP, ICH, FDA 21 CFR Part 11, EU-GMP (ANNEX 11), and ISPE GAMP5. With "Quality and Compliance Expert" as its management philosophy and market positioning, it helps pharmaceutical enterprises improve their quality and compliance levels, meet industry supervision requirements, accelerate the launch of more safe, effective, and high-quality products, and realize greater health value.
About Hippocrates
Named after Hippocrates, the father of ancient Greek medicine, Hippocrates has over 20 years of industry experience. The company started with GMP compliance consulting and has grown into a leading provider of pharmaceutical digital solutions in China. We have participated in the drafting of national GxP digital standards and possess strong capabilities in both consulting and independent R&D. Our products comply with GxP standards and meet the regulatory requirements of global authorities such as the NMPA, FDA, EMA, and WHO. Our self-developed QMS, DMS, and TMS suites rank among the top tier in China. We also offer VDR, eSIGN, PVS, EBR, WMS, CGT, and eMAH solutions, along with one-stop services covering compliance control, data governance, and CSV validation, supporting both group-level and global deployment. Our clients include leading domestic pharmaceutical companies, benchmark biotech enterprises, and multinational pharmaceutical companies. To date, we have helped hundreds of companies achieve zero-defect audits, empowering pharmaceutical enterprises in digital transformation, cost reduction, efficiency improvement, and global growth.
